688626 翔宇医疗
已收盘 06-22 15:00:01
资讯
新帖
简况
翔宇医疗:公司积极推进脑机接口产品的研发、注册工作
证券之星 · 06-22 16:57
翔宇医疗:公司积极推进脑机接口产品的研发、注册工作
6月22日翔宇医疗跌5.71%,长城消费增值混合A基金重仓该股
证券之星 · 06-22 16:41
6月22日翔宇医疗跌5.71%,长城消费增值混合A基金重仓该股
每周股票复盘:翔宇医疗(688626)拟募资不超13.66亿研发创新产品
证券之星 · 06-20
每周股票复盘:翔宇医疗(688626)拟募资不超13.66亿研发创新产品
翔宇医疗(688626)披露2026年度向特定对象发行A股股票预案,6月18日股价下跌0.84%
证券之星 · 06-18
翔宇医疗(688626)披露2026年度向特定对象发行A股股票预案,6月18日股价下跌0.84%
翔宇医疗(688626.SH)拟定增募资不超13.66亿元
智通财经 · 06-18
翔宇医疗(688626.SH)拟定增募资不超13.66亿元
翔宇医疗拟非公开发行股票募资不超过14亿元,用于项目投资及补充流动资金
美股速递 · 06-18
翔宇医疗拟非公开发行股票募资不超过14亿元,用于项目投资及补充流动资金
5月29日翔宇医疗跌5.03%,长城消费增值混合A基金重仓该股
证券之星 · 05-29
5月29日翔宇医疗跌5.03%,长城消费增值混合A基金重仓该股
每周股票复盘:翔宇医疗(688626)增选两名董事会成员
证券之星 · 05-24
每周股票复盘:翔宇医疗(688626)增选两名董事会成员
翔宇医疗(688626)披露2025年年度股东会决议公告,5月18日股价下跌1.74%
证券之星 · 05-18
翔宇医疗(688626)披露2025年年度股东会决议公告,5月18日股价下跌1.74%
【机构调研记录】宏利基金调研翔宇医疗
证券之星 · 04-29
【机构调研记录】宏利基金调研翔宇医疗
股市必读:翔宇医疗年报 - 第四季度单季净利润同比增长15.73%
证券之星 · 04-27
股市必读:翔宇医疗年报 - 第四季度单季净利润同比增长15.73%
每周股票复盘:翔宇医疗(688626)股东户数增37.97%,净利升10.33%
证券之星 · 04-26
每周股票复盘:翔宇医疗(688626)股东户数增37.97%,净利升10.33%
翔宇医疗(688626)3月31日股东户数1.37万户,较上期增加37.97%
证券之星 · 04-24
翔宇医疗(688626)3月31日股东户数1.37万户,较上期增加37.97%
图解翔宇医疗年报:第四季度单季净利润同比增长15.73%
证券之星 · 04-24
图解翔宇医疗年报:第四季度单季净利润同比增长15.73%
每周股票复盘:翔宇医疗(688626)股东减持57.31万股且提前终止计划
证券之星 · 04-12
每周股票复盘:翔宇医疗(688626)股东减持57.31万股且提前终止计划
翔宇医疗新注册《康复优选小程序V2》项目的软件著作权
证券之星 · 04-11
翔宇医疗新注册《康复优选小程序V2》项目的软件著作权
4月7日翔宇医疗发布公告,股东减持57.31万股
证券之星 · 04-07
4月7日翔宇医疗发布公告,股东减持57.31万股
每周股票复盘:翔宇医疗(688626)归还1亿元闲置募资
证券之星 · 04-05
每周股票复盘:翔宇医疗(688626)归还1亿元闲置募资
翔宇医疗(688626)披露归还暂时补充流动资金的闲置募集资金公告,4月3日股价下跌2.73%
证券之星 · 04-03
翔宇医疗(688626)披露归还暂时补充流动资金的闲置募集资金公告,4月3日股价下跌2.73%
中银国际:全球首款侵入式脑机产品获批 行业迈入商业化验证期
智通财经 · 03-16
中银国际:全球首款侵入式脑机产品获批 行业迈入商业化验证期
暂无数据
公司概况
公司名称:
河南翔宇医疗设备股份有限公司
所属行业:
专用设备制造业
上市日期:
2021-03-31
主营业务:
河南翔宇医疗设备股份有限公司的主营业务是康复医疗器械研发、生产、销售和服务。公司的主要产品是康复理疗设备类、康复训练设备类、康复评定设备类、经营及配件产品。作为国家级高新技术企业,翔宇医疗被国家中医药管理局认定为中医诊疗设备生产示范基地,被工信部认定为国家首批专精特新“小巨人”企业、获评体育领域国家级“专精特新”小巨人企业,被国家知识产权局评为国家知识产权示范企业,荣获河南省省长质量奖,翔宇医疗商标被国家工商行政管理总局评为中国驰名商标。
发行价格:
28.82
{"stockData":{"symbol":"688626","market":"SH","secType":"STK","nameCN":"翔宇医疗","latestPrice":45.38,"timestamp":1782111601000,"preClose":48.13,"halted":0,"volume":3444473,"delay":0,"changeRate":-0.0571,"floatShares":160000000,"shares":160000000,"eps":0.5033,"marketStatus":"已收盘","change":-2.75,"latestTime":"06-22 15:00:01","open":46.42,"high":47.17,"low":43.33,"amount":154000000,"amplitude":0.0798,"askPrice":45.38,"askSize":15,"bidPrice":45.37,"bidSize":48,"shortable":0,"etf":0,"ttmEps":0.5033,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782178200000},"marketStatusCode":5,"adr":0,"adjPreClose":48.13,"symbolType":"stock_kcb","openAndCloseTimeList":[[1782091800000,1782099000000],[1782104400000,1782111600000]],"highLimit":52.94,"lowLimit":43.32,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":160000000,"isCdr":false,"pbRate":3.45,"roa":"--","peRate":90.164912,"roe":"1.21%","epsLYR":0.51,"committee":-0.179191,"marketValue":7261000000,"turnoverRate":0.0215,"status":1,"afterMarket":{"amount":0,"volume":0,"close":45.38,"buyVolume":0,"sellVolume":0,"time":1782113637746,"indexStatus":"已收盘 06-22 15:30:00","preClose":48.13},"floatMarketCap":7261000000},"requestUrl":"/m/hq/s/688626/tweets","defaultTab":"tweets","newsList":[{"id":"2645028580","title":"翔宇医疗:公司积极推进脑机接口产品的研发、注册工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2645028580","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645028580?lang=zh_cn&edition=full","pubTime":"2026-06-22 16:57","pubTimestamp":1782118635,"startTime":"0","endTime":"0","summary":"证券之星消息,翔宇医疗(688626)06月22日在投资者关系平台上答复投资者关心的问题。投资者提问:公司的脑机设备营收占总营收的比例有多少,2026年的产品进展情况翔宇医疗回复:尊敬的投资者您好,公司积极推进脑机接口产品的研发、注册工作,具体进展受相关部门分类界定、审评进度等影响,2026年脑机接口产品销售情况主要受注册证取证进度等因素影响,感谢您对公司的关注和支持。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200024136.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645104091","title":"6月22日翔宇医疗跌5.71%,长城消费增值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645104091","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645104091?lang=zh_cn&edition=full","pubTime":"2026-06-22 16:41","pubTimestamp":1782117671,"startTime":"0","endTime":"0","summary":"证券之星消息,6月22日翔宇医疗跌5.71%创60日新低,收盘报45.38元,换手率2.15%,成交量3.44万手,成交额1.54亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共5家,其中持有数量最多的公募基金为长城基金的长城消费增值混合A。长城消费增值混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200023660.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644065899","title":"每周股票复盘:翔宇医疗(688626)拟募资不超13.66亿研发创新产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2644065899","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644065899?lang=zh_cn&edition=full","pubTime":"2026-06-20 02:39","pubTimestamp":1781894351,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘,翔宇医疗报收于48.13元,较上周的47.89元上涨0.5%。本周,翔宇医疗6月18日盘中最高价报49.68元。本周关注点来自公司公告汇总:翔宇医疗拟向特定对象发行A股股票,募集资金总额不超过13.66亿元,用于康复医疗创新产品研发及补充流动资金。本次拟发行股票数量不超过4800万股,募集资金总额不超过13.66亿元,发行对象不超过35名,锁定期六个月,发行价格不低于定价基准日前二十个交易日公司股票交易均价的80%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062000000811.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644609084","title":"翔宇医疗(688626)披露2026年度向特定对象发行A股股票预案,6月18日股价下跌0.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644609084","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644609084?lang=zh_cn&edition=full","pubTime":"2026-06-18 22:37","pubTimestamp":1781793436,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘,翔宇医疗报收于48.13元,较前一交易日下跌0.84%,最新总市值为77.01亿元。近日,翔宇医疗发布《2026年度向特定对象发行A股股票预案》。公告显示,公司拟向特定对象发行不超过4800万股A股股票,募集资金总额不超过13.66亿元,用于康复医疗创新产品研发项目及补充流动资金。发行对象不超过35名,发行价格不低于定价基准日前20个交易日公司股票交易均价的80%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800042715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159982","BK0251","688626","399300"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644508868","title":"翔宇医疗(688626.SH)拟定增募资不超13.66亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2644508868","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644508868?lang=zh_cn&edition=full","pubTime":"2026-06-18 19:28","pubTimestamp":1781782095,"startTime":"0","endTime":"0","summary":"智通财经APP讯,翔宇医疗(688626.SH)发布公告,公司拟向特定对象发行A股股票,募集资金总额不超过13.66亿元(含本数),扣除发行费用后的募集资金净额拟投入用于:康复医疗创新产品研发项目、补充流动资金。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1456367.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","688626"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142339892","title":"翔宇医疗拟非公开发行股票募资不超过14亿元,用于项目投资及补充流动资金","url":"https://stock-news.laohu8.com/highlight/detail?id=1142339892","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142339892?lang=zh_cn&edition=full","pubTime":"2026-06-18 19:27","pubTimestamp":1781782036,"startTime":"0","endTime":"0","summary":"翔宇医疗宣布,公司计划通过非公开发行股票的方式,募集资金总额不超过14亿元人民币。本次募集资金将主要用于特定项目的建设投资,以及补充公司日常运营所需的流动资金,以支持业务拓展和增强财务稳健性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0251","688626"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639062896","title":"5月29日翔宇医疗跌5.03%,长城消费增值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2639062896","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639062896?lang=zh_cn&edition=full","pubTime":"2026-05-29 16:43","pubTimestamp":1780044192,"startTime":"0","endTime":"0","summary":"证券之星消息,5月29日翔宇医疗跌5.03%创60日新低,收盘报51.4元,换手率1.19%,成交量1.91万手,成交额9951.86万元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共5家,其中持有数量最多的公募基金为长城基金的长城消费增值混合A。长城消费增值混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900030363.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637373911","title":"每周股票复盘:翔宇医疗(688626)增选两名董事会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=2637373911","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637373911?lang=zh_cn&edition=full","pubTime":"2026-05-24 02:32","pubTimestamp":1779561132,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘,翔宇医疗报收于56.71元,较上周的61.06元下跌7.12%。本周,翔宇医疗5月19日盘中最高价报66.01元。本周关注点公司公告汇总:翔宇医疗增选李治锋为职工代表董事、高云为独立董事,并调整董事会各专门委员会成员。2026年5月18日,公司召开2025年年度股东会,审议通过增选高云女士为第三届董事会独立董事。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400000604.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636307172","title":"翔宇医疗(688626)披露2025年年度股东会决议公告,5月18日股价下跌1.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636307172","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636307172?lang=zh_cn&edition=full","pubTime":"2026-05-18 22:17","pubTimestamp":1779113836,"startTime":"0","endTime":"0","summary":"截至2026年5月18日收盘,翔宇医疗报收于60.0元,较前一交易日下跌1.74%,最新总市值为96亿元。该股当日开盘60.9元,最高61.3元,最低59.48元,成交额达1.27亿元,换手率为1.32%。近日,河南翔宇医疗设备股份有限公司发布《2025年年度股东会决议公告》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800037352.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631558423","title":"【机构调研记录】宏利基金调研翔宇医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2631558423","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631558423?lang=zh_cn&edition=full","pubTime":"2026-04-29 08:13","pubTimestamp":1777421629,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及4月28日披露的机构调研信息,宏利基金近期对1家上市公司进行了调研,相关名单如下:1)翔宇医疗 调研纪要:2025年公司康复理疗设备收入同比略有落,主要系医保收费政策整合调整,院端需求阶段性承压。旗下最近一年表现最佳的公募基金产品为宏利成长混合,最新单位净值为6.04,近一年增长226.93%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900026143.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630933485","title":"股市必读:翔宇医疗年报 - 第四季度单季净利润同比增长15.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630933485","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630933485?lang=zh_cn&edition=full","pubTime":"2026-04-27 06:47","pubTimestamp":1777243628,"startTime":"0","endTime":"0","summary":"来自股本股东变化:截至2026年3月31日,翔宇医疗股东户数环比增长37.97%,达1.37万户。股本股东变化股东户数变动截至2026年3月31日,翔宇医疗股东户数为1.37万户,较2025年12月31日增加3772.0户,增幅37.97%;户均持股数量由1.61万股降至1.17万股,户均持股市值为66.17万元。业绩披露要点财务报告翔宇医疗2025年实现主营收入7.68亿元,同比增长3.26%;归母净利润7815.64万元,同比下降24.08%;扣非净利润5827.33万元,同比下降35.23%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700006814.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630666802","title":"每周股票复盘:翔宇医疗(688626)股东户数增37.97%,净利升10.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630666802","media":"证券之星","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630666802?lang=zh_cn&edition=full","pubTime":"2026-04-26 05:03","pubTimestamp":1777150993,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘,翔宇医疗报收于58.1元,较上周的59.5元下跌2.35%。本周,翔宇医疗4月20日盘中最高价报61.99元。本周关注点股本股东变化:截至2026年3月31日股东户数达1.37万户,较上年末增长37.97%业绩披露要点:2026年一季度归母净利润2532.2万元,同比增长10.33%股本股东变化股东户数变动截至2026年3月31日,翔宇医疗股东户数为1.37万户,较2025年12月31日增加3772.0户,增幅37.97%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600002195.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629081497","title":"翔宇医疗(688626)3月31日股东户数1.37万户,较上期增加37.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629081497","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629081497?lang=zh_cn&edition=full","pubTime":"2026-04-24 17:31","pubTimestamp":1777023109,"startTime":"0","endTime":"0","summary":"证券之星消息,近日翔宇医疗披露,截至2026年3月31日公司股东户数为1.37万户,较12月31日增加3772.0户,增幅为37.97%。在医疗器械行业个股中,翔宇医疗股东户数低于行业平均水平,截至3月31日,医疗器械行业平均股东户数为2.18万户。从股价来看,2025年12月31日至2026年3月31日,翔宇医疗区间跌幅为6.31%,在此期间股东户数增加3772.0户,增幅为37.97%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400052668.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629854331","title":"图解翔宇医疗年报:第四季度单季净利润同比增长15.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629854331","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629854331?lang=zh_cn&edition=full","pubTime":"2026-04-24 01:30","pubTimestamp":1776965453,"startTime":"0","endTime":"0","summary":"证券之星消息,翔宇医疗2025年年报显示,当年度公司主营收入7.68亿元,同比上升3.26%;归母净利润7815.64万元,同比下降24.08%;扣非净利润5827.33万元,同比下降35.23%;其中2025年第四季度,公司单季度主营收入2.31亿元,同比下降2.61%;单季度归母净利润3417.49万元,同比上升15.73%;单季度扣非净利润2833.37万元,同比上升10.94%;负债率36.34%,投资收益593.91万元,财务费用-1586.77万元,毛利率66.63%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400003697.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626812243","title":"每周股票复盘:翔宇医疗(688626)股东减持57.31万股且提前终止计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2626812243","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626812243?lang=zh_cn&edition=full","pubTime":"2026-04-12 02:06","pubTimestamp":1775930773,"startTime":"0","endTime":"0","summary":"截至2026年4月10日收盘,翔宇医疗报收于58.28元,较上周的55.5元上涨5.01%。本周关注点股本股东变化:股东安阳启旭减持57.31万股,占总股本0.3582%。股本股东变化股东增减持4月7日翔宇医疗发布公告,股东安阳启旭贸易咨询服务中心于2026年3月16日至2026年4月7日间合计减持57.31万股,占公司目前总股本的0.3582%。本次减持后,安阳启旭持股比例由5.38%降至2.43%,其一致行动人合计持股比例由67.59%降至64.64%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041200000585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626112372","title":"翔宇医疗新注册《康复优选小程序V2》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2626112372","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626112372?lang=zh_cn&edition=full","pubTime":"2026-04-11 01:53","pubTimestamp":1775843592,"startTime":"0","endTime":"0","summary":"证券之星消息,近日翔宇医疗新注册了《康复优选小程序V2》项目的软件著作权。今年以来翔宇医疗新注册软件著作权1个,较去年同期减少了80%。结合公司2025年中报财务数据,2025上半年公司在研发方面投入了8423.16万元,同比增28.27%。通过天眼查大数据分析,河南翔宇医疗设备股份有限公司共对外投资了45家企业,参与招投标项目3027次;财产线索方面有商标信息155条,专利信息2483条,著作权信息103条;此外企业还拥有行政许可633个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041100001391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","159180","688626"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625093046","title":"4月7日翔宇医疗发布公告,股东减持57.31万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2625093046","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625093046?lang=zh_cn&edition=full","pubTime":"2026-04-07 20:04","pubTimestamp":1775563488,"startTime":"0","endTime":"0","summary":"证券之星消息,4月7日翔宇医疗发布公告《翔宇医疗:翔宇医疗关于股东提前终止减持计划暨减持股份结果公告》,其股东安阳启旭贸易咨询服务中心(有限合伙)于2026年3月16日至2026年4月7日间合计减持57.31万股,占公司目前总股本的0.3582%,变动期间该股股价下跌21.97%,截止4月7日收盘报56.4元。股东增减持详情见下表:根据翔宇医疗2025年三季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700028833.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625761682","title":"每周股票复盘:翔宇医疗(688626)归还1亿元闲置募资","url":"https://stock-news.laohu8.com/highlight/detail?id=2625761682","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625761682?lang=zh_cn&edition=full","pubTime":"2026-04-05 01:51","pubTimestamp":1775325069,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘,翔宇医疗报收于55.5元,较上周的56.81元下跌2.31%。本周,翔宇医疗4月2日盘中最高价报59.96元。本周关注点公司公告汇总:翔宇医疗已全额归还此前用于补充流动资金的1亿元闲置募集资金。公司公告汇总翔宇医疗关于归还暂时补充流动资金的闲置募集资金的公告河南翔宇医疗设备股份有限公司于2025年4月15日召开董事会及监事会会议,审议通过使用不超过1亿元的闲置募集资金暂时补充流动资金,使用期限为12个月。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500000342.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624765980","title":"翔宇医疗(688626)披露归还暂时补充流动资金的闲置募集资金公告,4月3日股价下跌2.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624765980","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624765980?lang=zh_cn&edition=full","pubTime":"2026-04-03 17:25","pubTimestamp":1775208319,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘,翔宇医疗报收于55.5元,较前一交易日下跌2.73%,最新总市值为88.8亿元。该股当日开盘56.7元,最高57.5元,最低55.08元,成交额达1.14亿元,换手率为1.28%。翔宇医疗于2026年4月3日发布《关于归还暂时补充流动资金的闲置募集资金的公告》。公司实际使用1亿元闲置募集资金用于与主营业务相关的生产经营。截至2026年4月3日,公司已将上述1亿元全部归还至募集资金专用账户,使用期限未超期,并已通知保荐机构和保荐代表人。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300034326.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619458178","title":"中银国际:全球首款侵入式脑机产品获批 行业迈入商业化验证期","url":"https://stock-news.laohu8.com/highlight/detail?id=2619458178","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619458178?lang=zh_cn&edition=full","pubTime":"2026-03-16 16:05","pubTimestamp":1773648327,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,中银国际发布研报称,近日,国家药监局批准博睿康植入式脑机接口手部运动功能代偿系统创新产品注册申请,实现脑机接口全球首发上市,标志中国脑机接口产业从“技术验证”迈向“商业化落地”。投资建议随着全球首款侵入式产品获批上市,国内脑机接口产业已进入商业化验证期。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414283.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"中银国际:全球首款侵入式脑机产品获批 行业迈入商业化验证期","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688580","301363","688626","BK0251","688273","BK0077","301087","002173","BK0114","BK0236","BK0096","301293","300753"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782155373864,"stockEarnings":[{"period":"1week","weight":-0.0705},{"period":"1month","weight":-0.1969},{"period":"3month","weight":-0.1807},{"period":"6month","weight":-0.1536},{"period":"1year","weight":0.2829},{"period":"ytd","weight":-0.2472}],"compareEarnings":[{"period":"1week","weight":0.0161},{"period":"1month","weight":0.0122},{"period":"3month","weight":0.0726},{"period":"6month","weight":0.0564},{"period":"1year","weight":0.2391},{"period":"ytd","weight":0.0489}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"河南翔宇医疗设备股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"13705人(较上一季度增加37.97%)","perCapita":"11674股","listingDate":"2021-03-31","address":"河南省安阳市内黄县帝喾大道中段","registeredCapital":"16000万元","survey":" 河南翔宇医疗设备股份有限公司的主营业务是康复医疗器械研发、生产、销售和服务。公司的主要产品是康复理疗设备类、康复训练设备类、康复评定设备类、经营及配件产品。作为国家级高新技术企业,翔宇医疗被国家中医药管理局认定为中医诊疗设备生产示范基地,被工信部认定为国家首批专精特新“小巨人”企业、获评体育领域国家级“专精特新”小巨人企业,被国家知识产权局评为国家知识产权示范企业,荣获河南省省长质量奖,翔宇医疗商标被国家工商行政管理总局评为中国驰名商标。","listedPrice":28.82},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"翔宇医疗(688626)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供翔宇医疗(688626)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"翔宇医疗,688626,翔宇医疗股票,翔宇医疗股票老虎,翔宇医疗股票老虎国际,翔宇医疗行情,翔宇医疗股票行情,翔宇医疗股价,翔宇医疗股市,翔宇医疗股票价格,翔宇医疗股票交易,翔宇医疗股票购买,翔宇医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"翔宇医疗(688626)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供翔宇医疗(688626)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}